MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

January 2014


Pharmacovigilance Forum

Olmesartan and Drug-Induced Enteropathy

In three case histories, patients” sprue-like symptoms improved when olmesartan (Benicar) therapy was withheld.
Tran H. Tran, PharmD, BCPS; and Hanlin Li

New Congressional Bill Attempts to Aid Pharmacy Response to Drug Shortages

Compounding and Tracing Provisions Seek to Improve Quality of Drug Supply

The Drug Quality and Security Act is intended to prevent the sale of contaminated compounded agents, but the way in which facilities will be regulated is still unclear. Many safeguards will need to be implemented.
Stephen Barlas

New Oral Anticoagulants for Atrial Fibrillation

Are They Worth the Risk?

Dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) offer better efficacy over warfarin, and minimal monitoring is needed. However, there is no effective reversal agent, these new agents are not indicated for all patients, and there is limited information available about drug–drug and drug–disease interactions.
Hira Shafeeq, PharmD, BCPS; and Tran H. Tran, PharmD, BCPS

Meeting Highlights

American Heart Association Scientific Sessions 2013

Agents for Hypertension, Heart Failure, and Acute Myocardial Infarction

Topics include medications used in hypertension, heart failure, renal dysfunction, and myocardial infarction.
Walter Alexander


Medication Errors

Guidelines for Standard Order Sets

Following the guidelines for standard order sets minimizes incorrect prescribing.
Matthew Grissinger, RPh, FaScP

Prescription: Washington

Pharmacists, Deluged With Requirements, Pressure FDA to Standardize REMS Programs

Pharmacists want the FDA to standardize REMS programs.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Obinutuzumab (Gazyva) for chronic lymphocytic leukemia; ibrutinib (Imbruvica) for mantle-cell lymphoma; and sofosbuvir (Sovaldi) for chronic hepatitis C infection
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Ingenol Mebutate Gel (Picato)

A Novel Agent for the Treatment of Actinic Keratoses

Brooke Fidler, PharmD; and Tamara Goldberg, PharmD, BCPS